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A hepatitis E virus (HEV) vaccine would be valuable to reduce the morbidity and
mortality associated with the infection in endemic areas. HEV pseudocapsids and
epidermal delivery of HEV ORF2 DNA vaccine by gene-gun have been shown to confer
protection against virus challenge in monkeys. Vectorization of a DNA vaccine by virus-
like particles is a new immunization approach. We report here the successful
immunization of mice with two ORF2 genes encapsidated into human papillomavirus
type 31 virus-like particles. The HEV genes ORF2(112-660) and ORF2(112-608) were
optimized for expression in mammalian cells and inserted in a baculovirus-derived
vector for expression in insect cells. When expressed in Sf21 insect cells,
ORF2(112-660) led to the production of irregular 15 nm particles that accumulated in
the cytoplasm of the cells, whereas ORF2(112-608) induced the production of 18nm
particles that were present in both the cell culture medium and the cell cytoplasm.
Anti-HEV immune responses were higher for the 15 nm particles (HEV112-660) than
that for to the 18 nm particles (HEV112-608). Delivery into mice of two HEV ORF2
genes via a papillomavirus VLP was very effective in the induction of anti-HEV
antibodies. In addition, an effective immune response to human papillomavirus capsids
occurred. These engineered pseudoviruses were thus demonstrated to induce immune
responses to both hepatitis E virus and human papillomavirus when they were
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